Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 8, 2010

View Archived Issues

Preclinical and early clinical data reported on BC-3781

Extended proof-of-concept and drug interaction studies complete for IDX-899

Eisai details in vitro and in vivo activity of new antifungal E-1210

Researchers claim new glucokinase activators

SEPS Pharma presents new fluconazole prodrugs for fungal infections

Stemsynergy Therapeutics claims new Wnt signaling inhibitors

Deakin University presents new antibacterial agents

CH-14.18 shows promise in phase III trial in neuroblastoma

MV-062926 is active in mouse model of COPD

FDA accepts Accera's IND application for phase II/III AC-1204 trial in AD

NCI and Lixte Biotechnology collaborate on anticancer agent LB-100

ISTO Technologies' phase I trial of NuQu in discogenic back pain fully enrolled

NeuroSearch patents new voltage-gated K(V)7 potassium channel modulators

Roche buys rights to hepatitis C therapy danoprevir from InterMune

Sirius Genomics receives NRC-IRAP funding for discovery of genomic biomarkers

NIH funds Profectus BioSciences to develop HIV vaccine

Bepotastine besilate nasal spray is efficacious in allergic rhinitis

Sucampo submits marketing application for Amitiza in Japan

Xeomin launched in U.S. for cervical dystonia and blepharospasm

Pfizer acquires FoldRx Pharmaceuticals

FDA agrees to SPA for phase III Estybon trial in myelodysplastic syndromes

Recruitment complete in phase II tideglusib trial in progressive supranuclear palsy

DynPort Vaccine begins phase IIb trial of recombinant plague vaccine

ChemGenex completes pre-NDA meeting with FDA for Omapro

Neoprobe completes Lymphoseek pre-NDA meeting

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...